CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE IN PEDIATRIC ONCOLOGY

被引：2
|
作者：
KUSHNER, BH
CHEUNG, NKV
机构：
来源：
LANCET | 1990年 / 336卷 / 8709期
关键词：
D O I：
10.1016/0140-6736(90)91785-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [1] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE IN PEDIATRIC ONCOLOGY
    CHASTAGNER, P
    SOMMELETOLIVE, D
    LANCET, 1990, 336 (8722): : 1067 - 1068
  • [2] IFOSFAMIDE IN PEDIATRIC ONCOLOGY
    DEKRAKER, J
    ANTI-CANCER DRUGS, 1991, 2 (04) : 339 - 341
  • [3] IFOSFAMIDE, MESNA AND VINCRISTINE IN PEDIATRIC ONCOLOGY
    DEKRAKER, J
    VOUTE, PA
    CANCER TREATMENT REVIEWS, 1983, 10 : 165 - 166
  • [4] IFOSFAMIDE IN PEDIATRIC ONCOLOGY - TRIED BUT NOT TESTED
    SHAW, PJ
    EDEN, T
    LANCET, 1990, 335 (8696): : 1022 - 1023
  • [5] Cyclophosphamide versus ifosfamide: "To use ifosfamide or not to use, that is the three-dimensional question"
    Williams, ML
    Wainer, IW
    CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (08) : 665 - 672
  • [6] COMPARATIVE ACTIVITY OF IFOSFAMIDE AND CYCLOPHOSPHAMIDE
    BRADE, W
    SEEBER, S
    HERDRICH, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 : S1 - S9
  • [7] An overview of cyclophosphamide and ifosfamide pharmacology
    Fleming, RA
    PHARMACOTHERAPY, 1997, 17 (05): : S146 - S154
  • [8] Clinical Pharmacology of Cyclophosphamide and Ifosfamide
    Zhang, Jing
    Tian, Quan
    Zhou, Shu-Feng
    CURRENT DRUG THERAPY, 2006, 1 (01) : 55 - 84
  • [9] Urological implications of cyclophosphamide and ifosfamide
    Lawson, Malcolm
    Vasilaras, Arthur
    De Vries, Annamarie
    Mactaggart, Peter
    Nicol, David
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2008, 42 (04): : 309 - 317
  • [10] Ifosfamide and cyclophosphamide: Effects on immunosurveillance
    Binotto, G
    Trentin, L
    Semenzato, G
    ONCOLOGY, 2003, 65 : 17 - 20
12345